Stay informed with the latest updates for the inheritable blood disorders community. Medical CDC’s Director of NCBDDD Steps DownOct 29, 2014 Medical FDA Approves Baxter’s Obizur for Acquired Hemophilia AOct 29, 2014 Blood Safety PPTA Addresses Ebola and Plasma-Derived ProductsOct 16, 2014 Medical Gilead’s Harvoni®, First HCV Combination Pill, Approved by FDAOct 16, 2014 Medical PDF Now Available for Nurses’ Guide Chapter on ProphylaxisOct 16, 2014 Advocacy & Legislative HHS Announces 2015 Medicare Part B Premiums, Deductibles Remain UnchangedOct 10, 2014 Industry Enroll Now in HCV Clinical Trial for People with HemophiliaOct 7, 2014 Advocacy & Legislative FDA Holds Novel Patient-Focused Meeting on Bleeding DisordersSep 30, 2014 Industry Grifols Announces Larger Vial Size for ALPHANATE®Sep 29, 2014 Industry FDA Approves Baxter’s RIXUBIS for Children with Hemophilia BSep 25, 2014 NBDF & Community Relive Historic Annual Meeting Session on…Sep 25, 2014 NBDF & Community Did You Make a Capital Connection at NHF's Annual Meeting in DC?Sep 25, 2014 Industry Researchers Report Advances in Plant-based Hemophilia A TherapySep 10, 2014 Industry Achillion’s New HCV Treatment Performing Well in Phase 2 TrialSep 3, 2014 Industry Expression and ABL to Develop and Market High-Yield, Low-Cost rFVIIISep 3, 2014 Pagination First page Previous page … Page 71 Page 72 Page 73 Page 74 Current page 75 Page 76 Page 77 Page 78 Page 79 … Next page Last page
